Comparisons of urinary bladder responses to common antimuscarinics reveals unique effects of darifenacin
Darifenacin presents as an antimuscarinic medication that influences non-muscarinic pathways in urinary bladder tissue, indicating its potential to assist OAB patients with non-muscarinic pathophysiology.
Authors
- Russ Chess‐Williams (ORCID: https://orcid.org/0000-0002-7991-4117)
- Christian Moro (ORCID: https://orcid.org/0000-0003-2190-8301)
- Vineesha Veer (ORCID: https://orcid.org/0000-0002-0933-1952)
Institutions
- Bond University (AU)
Publication Details
- Journal
- Frontiers in Physiology
- Published
- 2025-02-20
- DOI
- https://doi.org/10.3389/fphys.2025.1534517
- Citations
- 1
- Primary Topic
- Urinary Bladder and Prostate Research
- Type
- article
- Field-Weighted Citation Impact
- 1.84
Funders
- Australian Government